Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of …

C Liu, W Wang, J Feng, B Beno, T Raja… - Bioorganic & Medicinal …, 2024 - Elsevier
As a result of our continued efforts to pursue Gal-3 inhibitors that could be used to fully
evaluate the potential of Gal-3 as a therapeutic target, two novel series of benzothiazole …
被引用次数：1 相关文章

Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of …

C Liu, W Wang, J Feng, B Beno, T Raja… - Bioorganic & …, 2024 - europepmc.org
As a result of our continued efforts to pursue Gal-3 inhibitors that could be used to fully
evaluate the potential of Gal-3 as a therapeutic target, two novel series of benzothiazole …

Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of …

C Liu, W Wang, J Feng, B Beno, T Raja… - Bioorganic & … - pubmed.ncbi.nlm.nih.gov
As a result of our continued efforts to pursue Gal-3 inhibitors that could be used to fully
evaluate the potential of Gal-3 as a therapeutic target, two novel series of benzothiazole …